{"id":"W2589575011","doi":"10.1200/jco.2012.30.4_suppl.448","title":"Phase II study of EZN-2208 (PEG-SN38) with or without cetuximab in patients with metastatic colorectal cancer (CRC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Cetuximab; Irinotecan; Internal medicine; Gastroenterology; Colorectal cancer; Rash; Nausea; Phases of clinical research; Adverse effect; Oxaliplatin; Cancer; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000946052,0.00131952,0.001785485,0.0003471199,0.0002930793,0.0006268934,0.0006751171,0.001144331,0.004228496],"category_scores_gemma":[0.0005923674,0.0006545921,0.0007704441,0.0003342174,0.0007554035,0.0006132802,0.0003030974,0.002330557,0.0009397862],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008418819,"about_ca_system_score_gemma":0.001664061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001293869,"about_ca_topic_score_gemma":0.003498557,"domain_scores_codex":[0.9996939,0.0001500148,0.00001252571,0.00005312321,0.00002454888,0.00006598107],"domain_scores_gemma":[0.9995709,0.00006091239,0.00006575826,0.00002707197,0.00002203817,0.0002532427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.81993,0.06318232,0.002933946,0.0007504718,0.000787526,0.0002034427,0.0001899831,0.00223578,0.04427499,0.0003186471,0.002867132,0.06232585],"study_design_scores_gemma":[0.5910126,0.3953576,0.006041003,0.00002220668,0.0003266196,0.0001640808,0.00004063511,0.001147739,0.003065799,0.0001552449,0.002647628,0.00001885133],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905358,0.001948543,0.0005798263,0.0004852861,0.0001866327,0.003205244,0.0007516671,0.0001073178,0.002199607],"genre_scores_gemma":[0.9870727,0.001785794,0.001517678,0.0007024294,0.0001806099,0.003087368,0.001356834,0.00002547588,0.004271074],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004228496,"threshold_uncertainty_score":0.01414573,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1275357734724543,"score_gpt":0.4963476226940474,"score_spread":0.368811849221593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}